Restriction proposal advances for a group of substances under REACH Annex XVII
A grouped restriction dossier has moved to the opinion-forming stage. Manufacturers, importers and downstream users should map affected uses and assess reformulation timelines now.
Published28 Aug 2026
EffectivePending final act
Compliance deadlineTransition period expected (typ. 18–24 months)
Read the full analysis